146 related articles for article (PubMed ID: 19457592)
1. [Serological markers in inflammatory bowel disease: differences among populations and limitations of their application].
Barahona-Garrido J; Hernández-Calleros J; Sarti HM; Cabiedes J; Yamamoto-Furusho JK
Gastroenterol Hepatol; 2009 May; 32(5):380-1. PubMed ID: 19457592
[No Abstract] [Full Text] [Related]
2. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
Desreumaux P; Bourreille A; Colombel JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
[No Abstract] [Full Text] [Related]
3. Clinical utility of serological markers in inflammatory bowel disease.
Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
[TBL] [Abstract][Full Text] [Related]
4. [Serologic disease markers in inflammatory bowel disease].
Domènech Morral E
Med Clin (Barc); 2004 Feb; 122(4):138-9. PubMed ID: 14967096
[No Abstract] [Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serological assays in pediatric inflammatory bowel disorders.
Mainardi E; Villanacci V; Bassotti G; Liserre B; Rossi E; Incardona P; Falchetti D; Tonegatti L; Montanelli A; Barabino A; Coccia C; Gambini C
Digestion; 2007; 75(4):210-4. PubMed ID: 17952008
[TBL] [Abstract][Full Text] [Related]
7. ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen?
Seibold F
Gut; 2005 Sep; 54(9):1212-3. PubMed ID: 16099786
[No Abstract] [Full Text] [Related]
8. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
Buckland MS; Mylonaki M; Rampton D; Longhurst HJ
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1328-30. PubMed ID: 16275949
[TBL] [Abstract][Full Text] [Related]
9. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
Hartman C; Eliakim R; Shamir R
Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
[No Abstract] [Full Text] [Related]
10. Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease.
Granito A; Muratori L; Muratori P; Guidi M; Lenzi M; Bianchi FB; Volta U
Gut; 2006 Feb; 55(2):296. PubMed ID: 16407392
[No Abstract] [Full Text] [Related]
11. Serological markers in inflammatory bowel diseases.
Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody.
Filik L; Biyikoglu I
World J Gastroenterol; 2008 Dec; 14(47):7271. PubMed ID: 19084948
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody: clinical tools or clues for research?
Griffiths AM; Zachos M
J Pediatr Gastroenterol Nutr; 2000 Jan; 30(1):1-2. PubMed ID: 10630428
[No Abstract] [Full Text] [Related]
14. [Diagnostic tools in inflammatory bowel diseases].
Bouhnik Y
Rev Prat; 2005 May; 55(9):977-83. PubMed ID: 16052968
[TBL] [Abstract][Full Text] [Related]
15. Positive and negative predictive values: use of inflammatory bowel disease serologic markers.
Austin GL; Shaheen NJ; Sandler RS
Am J Gastroenterol; 2006 Mar; 101(3):413-6. PubMed ID: 16542272
[No Abstract] [Full Text] [Related]
16. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.
Papadakis KA; Targan SR
Curr Gastroenterol Rep; 1999 Dec; 1(6):482-5. PubMed ID: 10980990
[TBL] [Abstract][Full Text] [Related]
17. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies.
Peña AS
Rev Esp Enferm Dig; 2003 Nov; 95(11):752-4, 749-51. PubMed ID: 14640872
[No Abstract] [Full Text] [Related]
18. Serological diagnosis of inflammatory bowel disease.
Rutgeerts P; Vermeire S
Lancet; 2000 Dec 23-30; 356(9248):2117-8. PubMed ID: 11191535
[No Abstract] [Full Text] [Related]
19. The value of serologic markers in indeterminate colitis: a prospective follow-up study.
Castillo S; Ramaiah B; Blum S; Remy P
Gastroenterology; 2003 Sep; 125(3):999; author reply 999-1000. PubMed ID: 12974272
[No Abstract] [Full Text] [Related]
20. [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers].
Terjung B; Spengler U; Sauerbruch T
Dtsch Med Wochenschr; 1999 Nov; 124(44):1314-20. PubMed ID: 10596294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
